Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ono Pharmaceutical CoFRA:ON4 +0.23%87 Dividend Yield % is 3.39% as of Jul. 14, 2026, which is 86% above its 10-year median of 1.82. GuruFocus rates FRA:ON4 with a GF Score™ of 87/100 and a GF Value™ of €12.10 (Fairly Valued). The stock has 4 warning signs investors should review. Among 516 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 72.87% on this metric.
As of today (2026-07-14), the Trailing Annual Dividend Yield of Ono Pharmaceutical Co is 3.39%.
Warning Sign:
Ono Pharmaceutical Co Ltd stock Dividend Yield % is close to 2-year low.
The historical rank and industry rank for Ono Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
FRA:ON4'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.91 Med: 1.82 Max: 5.33
Current: 3.39
During the past 13 years, the highest Dividend Yield of Ono Pharmaceutical Co was 5.33%. The lowest was 0.91%. And the median was 1.82%.
FRA:ON4's Dividend Yield % is ranked better than 72.87% of 516
companies
in the Drug Manufacturers industry
Industry Median: 1.93
vs FRA:ON4: 3.39
During the past 3 years, the average Dividends Per Share Growth Rate was 4.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 12.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 9.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ono Pharmaceutical Co was 44.20% per year. The lowest was 0.00% per year. And the median was 4.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Ono Pharmaceutical Co (FRA:ON4) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Ono Pharmaceutical Co Dividend Yield % Related Terms
Ono Pharmaceutical Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ON4 vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Dividend Yield % falls into.
Ono Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Ono Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 40.000000
2026-03-30
2026-03-31
2026-06-19
Cash Dividend
semi-annually
JPY:EUR 0.005438
JPY 40.000000
2025-09-29
2025-09-30
2025-12-01
Cash Dividend
semi-annually
JPY:EUR 0.005758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Ono Pharmaceutical Co's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (FRA:ON4) has a Dividend Yield % of 3.39% as of Jul. 14, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Ono Pharmaceutical Co and its competitors. This is 86% above median its historical median of 1.82. Over the past decade, Ono Pharmaceutical Co's Dividend Yield % has ranged from 0.91 to 5.33. According to the industry distribution chart, Ono Pharmaceutical Co ranks #140 out of 516 companies in the Drug Manufacturers industry, placing it in the top 27.1%.
Is Ono Pharmaceutical Co's Dividend Yield % too high?
Ono Pharmaceutical Co's current Dividend Yield % of 3.39% is 86% above median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 5.33. The Drug Manufacturers industry median Dividend Yield % is 1.93. Ono Pharmaceutical Co's value of 3.39% is 75.6% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #140 out of 516 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ono Pharmaceutical Co has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #140 out of 516 companies for Dividend Yield %. This puts Ono Pharmaceutical Co in the upper half of its industry. The industry median Dividend Yield % is 1.93. Ono Pharmaceutical Co's value of 3.39% is 75.6% above this benchmark. Historically, Ono Pharmaceutical Co's own Dividend Yield % has ranged from 0.91 to 5.33 over the past decade. While the company's 10-year median is 1.82 vs. the industry median of 1.93, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.93, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Dividend Yield % of 3.39% is 75.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Dividend Yield % is 3.39%, which is 86% above median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (FRA:ON4) is currently considered Fairly Valued. The stock's GF Value™ is €12.10, compared to a current price of €12.90 — trading 6.6% above its estimated fair value. The current Dividend Yield % is 3.39%, which is 86% above median its 10-year median of 1.82 and 75.6% above the Drug Manufacturers industry median of 1.93. Ono Pharmaceutical Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Ono Pharmaceutical Co (FRA:ON4), the current Dividend Yield % is 3.39% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (FRA:ON4) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of €12.90 is trading 6.6% above its estimated GF Value™ of €12.10.
GuruFocus considers Ono Pharmaceutical Co to be Fairly Valued.
Key valuation signals for FRA:ON4:
Dividend Yield %: 3.39% (86% above median its 10-year median of 1.82)
GF Value™: €12.10 vs. price of €12.90 (6.6% above fair value)
Industry Position: 75.6% above the Drug Manufacturers median (#140 of 516)
No single metric tells the full story. See the FRA:ON4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
87GF Score
Get the complete analysis for FRA:ON4
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ON4 has been successfully added to your 
